Cardiac resynchronization therapy offers a new therapeutic approach for treating patients with ventricular dysynchrony and moderate to severe HF. Early experience suggests that it is safe and effective, with patients demonstrating significant improvement in both clinical symptoms as well as multiple measures of functional status and exercise capacity. Ongoing and future clinical trials should help to further validate the role of cardiac resynchronization in the treatment of patients with systolic HF.